TNDM News

Latest breaking news and updates for TNDM stock.

Track all markets on TradingView

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tandem Diabetes Care, ...

What risk mitigation strategies should be considered for existing long or short positions in TNDM? How might this development influence investor sentiment and the positioning of institutional vs. retail holders? Is there any indication that the investigation pertains to specific financial disclosures, product performance data, or revenue recognition practices?
Lawsuits
6 days ago
Read more businesswire

Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) investors concerning the...

What is the likelihood of a class‑action settlement and how would any settlement proceeds be distributed to investors? Will this news affect the company's stock liquidity and bid‑ask spreads in the near term? What are the potential risks to the company's supply chain, customers, and partners stemming from this investigation?
Legal
7 days ago
Read more businesswire

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) on behalf of investors concerning ...

What contingency measures (e.g., insurance, reserves) does Tandem have in place to address potential legal costs? How might this development affect Tandem’s competitive position and partnership agreements? Is there any indication that the company’s management or board will resign or be replaced as a result?
Legal
7 days ago
Read more businesswire

Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related i...

Is there any indication that this correction will lead to a revision of Tandem's guidance or affect its upcoming earnings call? Could this issue influence investor sentiment toward the broader diabetes management market, potentially impacting related stocks or ETFs? What steps is Tandem taking to mitigate supply chain disruptions and prevent future device malfunctions?
Recalls
14 days ago
Read more businesswire

Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30,...

What technical or supply chain challenges were mentioned and how might they affect future production? What are the analyst reactions and target price revisions in response to these results? Is there any indication of changes in pricing, reimbursement, or insurance coverage that could impact future revenue?
Earnings
14 days ago
Read more businesswire